Compare THM & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | THM | CYRX |
|---|---|---|
| Founded | 1978 | 1999 |
| Country | Canada | United States |
| Employees | N/A | 1100 |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 723.2M | 421.6M |
| IPO Year | 2002 | 2008 |
| Metric | THM | CYRX |
|---|---|---|
| Price | $2.55 | $7.80 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $12.94 |
| AVG Volume (30 Days) | ★ 1.6M | 380.4K |
| Earning Date | 01-01-0001 | 06-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | N/A | ★ 1.40 |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | N/A | $9.71 |
| Revenue Next Year | N/A | $9.56 |
| P/E Ratio | ★ N/A | $5.51 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.46 | $4.63 |
| 52 Week High | $3.65 | $11.45 |
| Indicator | THM | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 41.87 | 36.51 |
| Support Level | $2.17 | $6.57 |
| Resistance Level | $3.63 | $7.88 |
| Average True Range (ATR) | 0.28 | 0.45 |
| MACD | -0.08 | -0.01 |
| Stochastic Oscillator | 3.13 | 11.43 |
International Tower Hill Mines Ltd is a mining company. It is engaged in the acquisition, exploration, and development of mineral properties. The company holds interests in an exploration project namely the Livengood Gold Project. It is located in northwest of Fairbanks, Alaska in the Tolovana mining district within the Tintina gold belt. The project property consists of land leased from the Alaska Mental Health Trust, several smaller private mineral leases, Alaska state mining claims purchased or located by the company, and the patented ground held by the company.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.